Literature DB >> 14609972

The trials and tribulations of doing drug research in children.

Doreen Matsui1, Charisse Kwan, Erin Steer, Michael J Rieder.   

Abstract

Entities:  

Keywords:  Biomedical and Behavioral Research

Mesh：

Year:  2003        PMID： 14609972      PMCID： PMC236228     

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  5 in total

1.  The Pediatric Pharmacology Research Unit (PPRU) Network and its role in meeting pediatric labeling needs.

Authors:  S N Cohen
Journal:  Pediatrics       Date:  1999-09       Impact factor: 7.124

2.  Regulations requiring manufacturers to assess the safety and effectiveness of new drugs and biological products in pediatric patients--FDA. Final rule.

Authors: 
Journal:  Fed Regist       Date:  1998-12-02

3.  Testing medications in children.

Authors:  Robert Steinbrook
Journal:  N Engl J Med       Date:  2002-10-31       Impact factor: 91.245

4.  Reported adverse drug events in infants and children under 2 years of age.

Authors:  Thomas J Moore; Sheila R Weiss; Sigal Kaplan; Carol J Blaisdell
Journal:  Pediatrics       Date:  2002-11       Impact factor: 7.124

5.  Unlicensed and off-label drug use: issues and recommendations.

Authors:  Sharon Conroy
Journal:  Paediatr Drugs       Date:  2002       Impact factor: 3.022
  5 in total
  6 in total

1.  Off-label and unlicensed prescribing for children: have we made any progress?

Authors:  D G Waller
Journal:  Br J Clin Pharmacol       Date:  2007-07       Impact factor: 4.335

2.  Researchers' perceptions of the ethical implications of pharmacogenomics research with children.

Authors:  D Avard; T Silverstein; G Sillon; Y Joly
Journal:  Public Health Genomics       Date:  2009-02-10       Impact factor: 2.000

3.  Infliximab for the treatment of paediatric Crohn's disease: Obstacles to accessing a necessary therapy.

Authors:  Anthony Otley; Jeff Critch; J Decker Butzner
Journal:  Paediatr Child Health       Date:  2004-02       Impact factor: 2.253

Review 4.  Design and conduct of early phase drug studies in children: challenges and opportunities.

Authors:  Michael Rieder; Daniel Hawcutt
Journal:  Br J Clin Pharmacol       Date:  2016-08-08       Impact factor: 4.335

Review 5.  Accepting risk in clinical research: is the gene therapy field becoming too risk-averse?

Authors:  Claire T Deakin; Ian E Alexander; Ian Kerridge
Journal:  Mol Ther       Date:  2009-09-22       Impact factor: 11.454

6.  Parents' agendas in paediatric clinical trial recruitment are different from researchers' and often remain unvoiced: a qualitative study.

Authors:  Kerry Woolfall; Valerie Shilling; Helen Hickey; Rosalind L Smyth; Emma Sowden; Paula R Williamson; Bridget Young
Journal:  PLoS One       Date:  2013-07-03       Impact factor: 3.240
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.